Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection

Respiratory syncytial virus (RSV) is a significant cause of pediatric respiratory tract infections. It is estimated that two-thirds of infants are infected with RSV during the first year of life and it is one of the leading causes of death in this age group worldwide. Similarly, bovine RSV is a prim...

Full description

Saved in:
Bibliographic Details
Published inVaccines (Basel) Vol. 7; no. 1; p. 7
Main Authors Guerra-Maupome, Mariana, Palmer, Mitchell V, McGill, Jodi L, Sacco, Randy E
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 08.01.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Respiratory syncytial virus (RSV) is a significant cause of pediatric respiratory tract infections. It is estimated that two-thirds of infants are infected with RSV during the first year of life and it is one of the leading causes of death in this age group worldwide. Similarly, bovine RSV is a primary viral pathogen in cases of pneumonia in young calves and plays a significant role in bovine respiratory disease complex. Importantly, naturally occurring infection of calves with bovine RSV shares many features in common with human RSV infection. Herein, we update our current understanding of RSV infection in cattle, with particular focus on similarities between the calf and human infection, and the recent reports in which the neonatal calf has been employed for the development and testing of vaccines and therapeutics which may be applied to hRSV infection in humans.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines7010007